PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 105 filers reported holding PULMONX CORP in Q3 2022. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258,602 | -70.1% | 25,034 | -62.1% | 0.00% | – |
| Q2 2023 | $864,879 | -2.3% | 65,971 | -16.7% | 0.00% | – |
| Q1 2023 | $885,176 | +28.8% | 79,175 | -2.9% | 0.00% | – |
| Q4 2022 | $687,213 | -38.4% | 81,520 | +21.7% | 0.00% | – |
| Q3 2022 | $1,116,000 | +38.5% | 66,983 | +22.3% | 0.00% | – |
| Q2 2022 | $806,000 | -37.3% | 54,783 | +5.8% | 0.00% | – |
| Q1 2022 | $1,285,000 | +102.7% | 51,799 | +161.8% | 0.00% | – |
| Q4 2021 | $634,000 | +1.8% | 19,787 | +14.1% | 0.00% | – |
| Q3 2021 | $623,000 | -50.7% | 17,345 | -39.4% | 0.00% | – |
| Q2 2021 | $1,263,000 | -29.5% | 28,629 | -26.9% | 0.00% | – |
| Q1 2021 | $1,792,000 | +4270.7% | 39,172 | +6561.9% | 0.00% | – |
| Q4 2020 | $41,000 | – | 588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |